← Eichor
Study identifier: NCT07690514 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Theta Burst Transcranial Focused Ultrasound as a Novel Treatment for Cervical Dystonia

Condition: Cervical Dystonia  ·  Sponsor: Robert Chen

PhaseNA
Planned participants48
Who can joinAll sexes, 18 Years to 90 Years
Healthy volunteersNo

About this study

This study is a single-blinded, randomized control study that aims to recruit 48 participants. Participants will be "randomized" into one of the study arms of the study: active stimulation to GPi, active stimulation to DN, or sham stimulation. The purpose of the study is to look into the effects of LIFUS in patients with cervical dystonia. The participation will include seven study visits, at least 24 hours apart. All study visits will take place at TWH. The first visit is a screening visit. Visits 2-6 will be on consecutive days. Visit 7 will be a week from Visit 6 or from your last day of LIFUS, whichever comes first.

This description comes directly from the study's public registry record.

Talk to the study team

Jean-Francois Nankoo, PhD  ·  416-603-5792  ·  jean-francois.nankoo@uhn.ca

Julian Kwok  ·  416-603-5800  ·  julian.kwok@uhn.ca

Always discuss trial participation with your own doctor first.

Locations (1)

Toronto Western HospitalToronto, Ontario, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07690514